MTOR and glioblastoma: Moreover, dual inhibition of Akt and mTOR has proven effective in pre-clinical model of GBM [23], suggesting that dual Akt/mTOR inhibitor can effectively overcome the effects of feeback loop efficiently than a single inhibitor selectively targeting mTOR.